Lupin Limited, a pharmaceutical company based in Mumbai, India, is engaged in the development, production, marketing, and sale of a wide range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs). The company offers formulations for various therapeutic areas including cardiovascular, diabetology, asthma, pediatrics, central nervous system, gastrointestinal, anti-infective, nonsteroidal anti-inflammatory drug therapy, respiratory, women's health, and anti-tuberculosis. Additionally, Lupin Limited is involved in the provision of biosimilar and over-the-counter products, specialty products, and drug discovery and development programs in the fields of oncology, immunology, and metabolic disorders. The company's extensive network comprises 18 labs, 280 LupiMitra collection centers, and 450 pick-up points. Lupin Limited operates not only in India but also in several other countries such as the United States, the United Kingdom, South Africa, Australia, the Philippines, Germany, the Netherlands, Mexico, and Brazil. Originally known as Lupin Chemicals Limited, the company changed its name to Lupin Limited in 2001 following its merger with Lupin Laboratories Limited. Established in 1968, Lupin Limited has established itself as a prominent player in the pharmaceutical industry.
Navigation section
Lupin Limited
- 2,135.85 31.15(1.48%) 2,130.00 23.35(1.11%)
Performance
| Today's Low | Today's High | |
|---|---|---|
| 2,105.25 2,106.80 | 2,144.50 2144.00 |
| 52 Week Low | 52 Week High | |
|---|---|---|
| 1,200.15 (21-Dec-2023) 1,200.35 (21-Dec-2023) | 2,312.00 (05-Sep-2024) 2,312.00 (05-Sep-2024) |
- Open
- 2,111.10 2,106.80
- Previous Close
- 2,104.70 2,106.65
- Volume
- 9.43
- Total Traded value
- 200.95 (₹ Lakhs)
- Upper circuit
- 2,315.15 1,538.25
- Lower circuit
- 1,894.25 1,258.65
Market Depth
| Buy Order Quantity | Sell Order Quantity | |
|---|---|---|
| 0 | 57 |
| Bid Price | Quantity |
|---|---|
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | -- |
| Ask Price | Quantity |
|---|---|
| 2,134.05 | 57.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | 57 |
Fundamentals
| Market Cap: | ₹974.37 Cr |
| PE Ratio (TTM): | 32.42 |
| PB Ratio: | 4.42 |
| Industry P/E: | 36.21 |
| Debt to Equity: | - |
| ROE: | 13.64 |
| EPS (TTM): | 65.71 |
| Book Value: | 0.00 |
| Face Value: | 2.00 |
Financials
| Jun, 2023 | Jun, 2023 | Jun, 2023 | Jun, 2023 | Jun, 2023 | |
|---|---|---|---|---|---|
| Revenue | 39.45 Cr | 160.96 Cr | 976.85 Cr | 1.23 Cr | 3,495.64 Cr |
| Profit | 2.26 Cr | -38.39 Cr | 116.67 Cr | -0.79 Cr | 476.96 Cr |
| Expense | 36.48 Cr | 217.15 Cr | 833.15 Cr | 2.04 Cr | 2,946.85 Cr |
| Comprehensive income | 2.26 Cr | -38.38 Cr | 116.78 Cr | -0.79 Cr | 477.45 Cr |
| EPS | 0.43 | -14.28 | 103.57 | -0.16 | 10.44 |
| Company name | Listing date | Industry | NSE symbol BSE symbol |
|---|---|---|---|
| Lupin Limited | Sep, 2001 Oct, 1993 | Pharmaceuticals Pharmaceuticals | LUPIN LUPIN |
Shareholding pattern
Sep, 2023 Jun, 2023 Mar, 2023 Dec, 2022 Sep, 2022
Lupin Limited FAQ's
What is the range of today's stock performance for Lupin Limited?
Today's stock performance witnessed a fluctuation from a minimum of 2,105.25 on the NSE (National Stock Exchange) to a maximum of 2,144.50. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 2,106.80 to a high of 2,144.00.
What are the 52-week low and high values for Lupin Limited?
The stock's performance over the past 52 weeks reveals a low of 1,200.15 (occurred on 21-Dec-2023) and a high of 2,312.00 (achieved on 05-Sep-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 1,200.35 (on 21-Dec-2023), and the 52-week high is 2,312.00 (on 05-Sep-2024).
What was the opening and previous closing prices for Lupin Limited?
The stock's performance over the past 52 weeks reveals a low of 1,200.15 (occurred on 21-Dec-2023) and a high of 2,312.00 (achieved on 05-Sep-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 1,200.35 (on 21-Dec-2023), and the 52-week high is 2,312.00 (on 05-Sep-2024).
What is the total volume and traded value for Lupin Limited for the day?
The total volume is 9, and the total traded value is 200.95 (₹ Lakhs).
What are the upper and lower circuit limits for Lupin Limited?
The upper circuit limit is 2,315.15, and the lower circuit limit is 1,894.25.
What is the market cap and PE ratio for Lupin Limited?
The market cap is ₹974.37 Cr, and the PE ratio (TTM) is 36.21.
What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Lupin Limited?
ROE is 13.64, EPS is 65.71, book value is not available
What are the revenue and profit figures for the latest quarter and previous quarters for Lupin Limited?
In Jun 2023, Revenue is ₹394500000.00, and Profit is ₹22600000.00. In Jun 2023, Revenue is ₹1609612000.00, and Profit is ₹-383928000.00.
When was Lupin Limited listed, and what industry does it belong to?
The company, Lupin Limited, was listed in Sep 2001 and belongs to the Pharmaceuticals industry. Its NSE symbol is LUPIN.
What is the current shareholding pattern of the Lupin Limited?
As of latest available update, promoters hold 47.06%, the public holds 52.94%, and Employee Trusts holds 0.00.
The Indian Community
Public Community
Settings
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.
- Members
- 29
- Threads
- 96
